Telomir Pharmaceuticals, Inc. Common Stock (TELO)
USD 4.67
(-4.89%)
USD 4.67
(-4.89%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | 3.94 Million | - | - |
| Gross Profit | -3.94 Million | - | - |
| Operating Expenses | 3.94 Million | 854.14 Thousand | 138.13 Thousand |
| Selling, General and Administrative Expenses | 600.19 Thousand | 20.94 Thousand | 11.63 Thousand |
| Research and Development Expenses | 1.57 Million | 833.2 Thousand | 126.49 Thousand |
| Other Expenses | - | - | - |
| Cost and Expenses | 3.94 Million | 854.14 Thousand | 138.13 Thousand |
| Operating Income | -3.94 Million | -854.14 Thousand | -138.13 Thousand |
| Interest Expense | 1.64 Million | - | - |
| Income Tax Expense | - | -854.14 Thousand | -138.13 Thousand |
| Earnings before Tax | -13.07 Million | -854.14 Thousand | -138.13 Thousand |
| Net Income | -13.07 Million | -854.14 Thousand | -138.13 Thousand |
| Earnings Per Share Basic | -0.44 | -0.03 | -0.00 |
| Earnings Per Share Diluted | -0.44 | -0.03 | -0.00 |
| Weighted Average Shares Outstanding | 29.6 Million | 29.6 Million | 29.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.6 Million | 29.6 Million | 29.6 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -6.11 Million | -854.14 Thousand | -138.13 Thousand |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.47 Million | 1.91 Million | 3.94 Million | - | - | - |
| Gross Profit | -1.47 Million | -1.91 Million | -3.94 Million | - | - | - |
| Operating Expenses | 1.47 Million | 1.91 Million | 3.94 Million | 1.07 Million | 954.15 Thousand | 1.42 Million |
| Selling, General and Administrative Expenses | 879.69 Thousand | 741.54 Thousand | - | 395.29 Thousand | 102.19 Thousand | 60.1 Thousand |
| Research and Development Expenses | 594.8 Thousand | 804.02 Thousand | - | 203.78 Thousand | 262.56 Thousand | 667.62 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.47 Million | 1.91 Million | 3.94 Million | 1.07 Million | 954.15 Thousand | 1.42 Million |
| Operating Income | -1.47 Million | -1.91 Million | -3.94 Million | -8.56 Million | -954.15 Thousand | -1.42 Million |
| Interest Expense | - | 4.33 Million | 1.64 Million | 761.82 Thousand | 757.17 Thousand | 124.05 Thousand |
| Income Tax Expense | - | -1.91 Million | -2.29 Million | -1.07 Million | -954.15 Thousand | -1.42 Million |
| Earnings before Tax | -1.44 Million | -6.25 Million | -13.07 Million | -9.32 Million | -1.71 Million | -1.55 Million |
| Net Income | -1.44 Million | -6.25 Million | -13.07 Million | -9.32 Million | -1.71 Million | -1.55 Million |
| Earnings Per Share Basic | -0.05 | -0.23 | - | -0.32 | -0.06 | -0.05 |
| Earnings Per Share Diluted | -0.05 | -0.23 | - | -0.32 | -0.06 | -0.05 |
| Weighted Average Shares Outstanding | 29.6 Million | 27.76 Million | 29.6 Million | 29.6 Million | 29.6 Million | 29.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.6 Million | 27.76 Million | 29.6 Million | 29.6 Million | 29.6 Million | 29.6 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.47 Million | -1.91 Million | - | -8.56 Million | -954.15 Thousand | -1.42 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
TIP
HUML
4310
NKLA
ROST
PZZA